Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $687.57 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $327.05 | 26 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $135.00 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $48.00 | 2 | $0 (2021) |
| Esperion Therapeutics, Inc. | $42.57 | 2 | $0 (2021) |
| ITI, Inc. | $31.37 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $29.55 | 2 | $0 (2021) |
| Medtronic, Inc. | $20.48 | 1 | $0 (2021) |
| Amgen Inc. | $20.06 | 1 | $0 (2021) |
| Alkermes, Inc. | $19.19 | 1 | $0 (2022) |
| USWM, LLC | $14.30 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $59.50 | 2 | ABBVIE INC. ($59.50) |
| 2022 | $181.47 | 9 | ABBVIE INC. ($145.74) |
| 2021 | $446.60 | 28 | AstraZeneca Pharmaceuticals LP ($135.00) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: CNS | ||||||
| 03/29/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Neuroscience | ||||||
| 09/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: PSYCHIATRY | ||||||
| 06/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 444 | 637 | $75,977 | $17,221 |
| 2022 | 2 | 34 | 34 | $6,850 | $2,084 |
| 2021 | 1 | 12 | 12 | $1,995 | $693.46 |
| 2020 | 1 | 11 | 11 | $2,145 | $719.51 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 189 | $38,766 | $9,028 | 23.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $14,386 | $2,964 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 30 | $8,790 | $2,068 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,985 | $1,554 | 26.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 33 | 33 | $1,828 | $468.36 | 25.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 26 | $1,100 | $421.72 | 38.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 18 | 18 | $740.00 | $291.60 | 39.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 36 | $1,560 | $244.06 | 15.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 35 | 36 | $648.00 | $122.76 | 18.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 13 | $272.00 | $26.40 | 9.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 15 | 62 | $1,782 | $23.01 | 1.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 120 | $120.00 | $8.79 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 17 | $3,313 | $1,049 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,537 | $1,036 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $1,995 | $693.46 | 34.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 11 | $2,145 | $719.51 | 33.5% |
About Beth Gachuki
Beth Gachuki is a Physician Assistant healthcare provider based in Lumberton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1811479439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Gachuki has received a total of $687.57 in payments from pharmaceutical and medical device companies, with $59.50 received in 2023. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($687.57).
As a Medicare-enrolled provider, Gachuki has provided services to 501 Medicare beneficiaries, totaling 694 services with total Medicare billing of $20,718. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Lumberton, NC
- Active Since 08/30/2018
- Last Updated 09/29/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1811479439
Products in Payments
- VRAYLAR (Drug) $327.05
- BREZTRI (Drug) $135.00
- LATUDA (Drug) $48.00
- NEXLETOL (Drug) $42.57
- CAPLYTA (Drug) $31.37
- AUSTEDO (Drug) $29.55
- Guardian Connect (Device) $20.48
- Aimovig (Biological) $20.06
- ARISTADA (Drug) $19.19
- SYMJEPI (Drug) $14.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lumberton
Arbus Locklear, Pac, PAC
Physician Assistant — Payments: $8,700
Meredith Stocklin, Pa-C, PA-C
Physician Assistant — Payments: $5,964
Barry Graham, Pa-C, PA-C
Physician Assistant — Payments: $2,153
Mrs. Jennifer Taylor, Pa-C, PA-C
Physician Assistant — Payments: $1,740
Mrs. Victoria Locklear, Pa-C, PA-C
Physician Assistant — Payments: $1,399
Grace Davis
Physician Assistant — Payments: $1,244